The HPNA research agenda for 2009-2012

Journal of Hospice and Palliative Nursing

Volumn 11, Issue 1, 2009, Pages 10-18

  Campbell, Margaret L ^a   Happ, Mary Beth ^b   Hultman, Todd ^c   Kirchhoff, Karin T ^d   Mahon, Margaret M ^e   Mayo, M Murray ^f   McMillan, Susan ^g   Raudonis, Barbara ^h  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e GEORGE MASON UNIVERSITY   (United States)

^f Ursuline College   (United States)

^g UNIVERSITY OF SOUTH FLORIDA   (United States)

^h UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349410302     PISSN: 15222179     EISSN: 15390705     Source Type: Journal    
DOI: 10.1097/NJH.0b013e31819228d1     Document Type: Article

References (74)

1. Field MJ, Cassel CK, eds. Approaching Death: Improving Care at the End of Life. Washington, DC: National Academy Press; 1997.
2. National Consensus Project for Quality Palliative Care. Clinical Practice Guidelines for Quality Palliative Care. http://www. nationalconcensusproject. org. Accessed November 21, 2008.
3. National Institutes of Health. State of the science conference statement on improving end-of-life care. Paper presented at: NIH State of the ScienceConference; December 6-8, 2004; Bethesda,MD.
4. Center for Disease Control. National Center for Health Statistics. Hyattsville, MD: Department of Health and Human Services; 2007.
5. McMillan SC, Dunbar SB, ZhangW. The prevalence of symptoms in hospice patients with end-stage heart disease. J Hospice Palliat Nurs. 2007;9:124-131.
6. Goodman M, Low J, Wilkinson S. Constipation management in palliative care: a survey of practices in the United kingdom. J Pain Symptom Manage. 2005;29(3):238-244.
7. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58-69.
8. Rhodes VA, Watson PM. Symptom distressVthe concept. Semin Oncol Nurs. 1987;3(4):242-247.
9. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20(3):403-417.
10. Campbell ML. Fear and pulmonary stress behaviors to an asphyxial threat across cognitive states. Res Nurs Health. 2007; 30(6):572-583.
11. Campbell ML. Respiratory distress: a model of responses and behaviors to an asphyxial threat for patients who are unable to self-report. Heart Lung. 2008;37(1):54-60.
12. Gift AG, Narsavage G. Validity of the numeric rating scale as a measure of dyspnea. Am J Crit Care. 1998;7:200-204.
13. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehab Med. 1970;2-3:92-98.
14. Campbell ML. Psychometric testing of a respiratory distress observation scale. J Palliat Med. 2008;11(1):44-50.
15. Barach AL. Chronic obstructive lung disease: postural relief of dyspnea. Arch Phys Med Rehab. 1974;55:494-504.
16. Sharp JT, Drutz WS, Moisan T, Foster J, Machnach W. Postural relief of dyspnea in severe chronic obstructive lung disease. Am Rev Respir Dis. 1980;122:201-211.
17. Swinburn CR, Mould H, Stone TN, Corris PA, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis. 1991; 143:913-915.
18. Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnoea in hypoxaemic terminal-cancer patients. Lancet. 1993;342:13-14.
19. Burgess KR, Whitelaw WA. Reducing ventilatory response to carbon dioxide by breathing cold air. Am Rev Respir Dis. 1984; 129:687-690.
20. Burgess KR, Whitelaw WA. Effects of nasal cold receptors on pattern of breathing. J Appl Physiol. 1988;64:371-376.
21. Liss HP, Grant BJB. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137:1285-1288.
22. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136:58-61.
23. Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. J Pain Palliat Care Pharmacother. 2004;18(4):3-15.
24. Wilson RH, Hoseth W, Dempsey ME. Respiratory acidosis: effects of decreasing respiratory minute volume in patients with severe chronic pulmonary emphysema, with specific reference to oxygen, morphine and barbiturates. Am J Med. 1954;17:464-470.
25. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-944.
26. Light RW, Stansbury DW, Webster JS. Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD. Chest. 1996;109: 975-981.
27. Navigante AH, Cerchietti LC, Castro MA, Lutteral MA, Cabalar ME. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006;31(1):38-47.
28. Campbell ML. How to withdraw mechanical ventilation: a systematic review of the literature. AACN Adv Crit Care. 2007; 18(4):397-403.
29. Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care, part II: cachexia/anorexia and fatigue. J Palliat Med. 2006; 9(2):409-421.
30. Yennurajalingam S, Bruera E. Palliative management of fatigue at the close of life: ''it feels like my body is just worn out.'' JAMA. 2007;297(3):295-304.
31. Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27-43.
32. Anderson PA, Dean GE. Fatigue. In: Ferrell BR, Coyle N, eds. Textbook of Palliative Nursing. 2nd ed. New York, NY: Oxford University Press; 2006.
33. Saleem T, Leigh PN, Higginson IJ. Symptom prevalence among people affected by advanced and progressive neurological conditionsVa systematic review. J Palliat Care. 2007;23(4): 291-299.
34. Evangelista LS, Moser DK, Westlake C, Pike N, Ter-Galstanyan A, Dracup K. Correlates of fatigue in patients with heart failure. Prog Cardiovasc Nurs. 2008;23:12-17.
35. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147-153.
36. Reddy S, Bruera E, Pace E, Zhang K, Reyes-Gibby CC. Clinically important improvement in the intensity of fatigue in patients with advanced cancer. J Palliat Med. 2007;10(5):1068-1075.
37. Cella D, Webster K. Linking outcomes management to qualityof- life measurement. Oncology (Williston Park). 1997;11(11A): 232-235.
38. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989;46(10): 1121-1123.
39. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer. 1999;85(5):1186-1196.
40. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM. The revised Piper Fatigue Scale: psychometric evaluation in women with breast cancer. Oncol Nurs Forum. 1998;25(4): 677-684.
41. Hann DM, Denniston MM, Baker F. Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res. 2000;9(7):847-854.
42. Ashman TA, Cantor JB, Gordon WA, et al. Objective measurement of fatigue following traumatic brain injury. J Head Trauma Rehab. 2008;23(1):33-40.
43. Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist. 2007;12(suppl 1):52-67.
44. Cramp F, Daniel J. Exercise for the management of cancerrelated fatigue in adults. Cochrane Database Syst Rev. 2008;(2): CD006145.
45. Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest. 2005;23(3): 229-239.
46. Pucci E, Branas P, D'Amico R, Giuliani G, Solari A, Taus C. Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev. 2007;(1):CD002818.
47. Minton O, Stone P, Richardson A, Sharpe M, Hotopf M. Drug therapy for the management of cancer related fatigue. Cochrane Database Syst Rev. 2008;(1):CD006704.
48. Radbruch L, Elsner F, Krumm N, Peuckmann V, Trottenberg P. Drugs for the treatment of fatigue in palliative care. Cochrane Database Syst Rev. 2007;(4) Art. No.: CD006788.
49. Radbruch L, Strasser F, Elsner F, et al. Fatigue in palliative care patientsVan EAPC approach. Palliat Med. 2008;22(1):13-32.
50. Yuan CS. Handbook of Opioid Bowel Syndrome. Binghampton, NY: Hayworth Press; 2005.
51. Bracci F, Badiali D, Pezzotti P, et al. Chronic constipation in hemiplegic patients. World J Gastroenterol. 2007;13(29): 3967-3972.
52. Foxx-Orenstein AE, Camilleri M, Szarka LA, et al. Does coadministration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipationpredominant irritable bowel syndrome? A randomized controlled trial. Neurogastroenterol Motil. 2007;19(10):821-830.
53. Hosia-Randell H, Suominen M, Muurinen S, Pitkala KH. Use of laxatives among older nursing home residents in Helsinki, Finland. Drugs Aging. 2007;24(2):147-154.
54. Lundorff L, Peuckmann V, Sjogren P. Pain management of opioidtreated cancer patients in hospital settings in Denmark. Acta Anaesthesiol Scand. 2008;52(1):137-142.
55. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82-99.
56. Tsoussis S, Ikonomidou F, Vourliotaki I, Papadaki A, Apostolakis S. Clinical burden of terminal phase in cancer patients. J Buon. 2007;12(3):383-388.
57. Hale EM, Smith E, St James J, Wojner-Alexandrov AW. Pilot study of the feasibility and effectiveness of a natural laxative mixture. Geriatr Nurs. 2007;28(2):104-111.
58. Hale M, Tudor IC, Khanna S, Thipphawong J. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, openlabel, noninferiority analysis. Clin Ther. 2007;29(5):874-888.
59. Rodriguez RF, Castillo JM, Del Pilar Castillo M, et al. Codeine/ acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study. Clin Ther. 2007;29(4):581-587.
60. Watson MS, Lucas CF, Hoy AM, Back IN. Oxford Handbook of Palliative Care. New York, NY: Oxford University Press; 2005.
61. McMillan SC, Tittle M, Hagan S, Laughlin J. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs. 2000;23(5):327-336.
62. Max EK, Hernandez JJ, Sturpe DA, Zuckerman IH. Prophylaxis for opioid-induced constipation in elderly long-term care residents: a cross-sectional study of Medicare beneficiaries. Am J Geriatr Pharmacother. 2007;5(2):129-136.
63. Portenoy RK, Farrar JT, Backonja MM, et al. Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry study. Clin J Pain. 2007;23(4):287-299.
64. van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol. 2007;82(11):955-960.
65. Weschules DJ, Bain KT, Reifsnyder J, et al. Toward evidencebased prescribing at end of life: a comparative analysis of sustained-release morphine, oxycodone, and transdermal fentanyl, with pain, constipation, and caregiver interaction outcomes in hospice patients. Pain Med. 2006;7(4):320-329.
66. Valenzuela ACT, Diaz-Zuluaga PA. Opioid induced bowel dysfunction. AAHPM Summer Bulletin; 2007;8(2):6-8.
67. Morgan JC, Sethi KD. Tegaserod in constipation associated with Parkinson disease. Clin Neuropharmacol. 2007;30(1):52-54.
68. DiPalma JA, Cleveland MB, McGowan J, Herrera JL. A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications. South Med J. 2007;100(11):1085-1090.
69. Thomas J, Karver S, Cooney GA, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;358(22):2332-2343.
70. McMillan SC, Small BJ. Using the COPE intervention for family caregivers to improve symptoms of hospice homecare patients: a clinical trial. Oncol Nurs Forum. 2007;34(2):313-321.
71. Sakakibara R, Yamaguchi T, Uchiyama T, et al. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects. Mov Disord. 2007; 22(11):1672-1673.
72. Benton D, Williams C, Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr. 2007;61(3):355-361.
73. Sairanen U, Piirainen L, Nevala R, Korpela R. Yoghurt containing galacto-oligosaccharides, prunes and linseed reduces the severity of mild constipation in elderly subjects. Eur J Clin Nutr. 2007; 61(12):1423-1428.
74. Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: a systematic review. JAMA. 2008;299(14):1698-1709.